Literature DB >> 18057383

Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations.

Z Gombos1, R Hermann, M Kiviniemi, S Nejentsev, K Reimand, V Fadeyev, P Peterson, R Uibo, J Ilonen.   

Abstract

OBJECTIVE: Addison's disease is an organ-specific autoimmune disorder with a polygenic background. The aim of the study was to identify non-class II human leukocyte antigen (HLA) susceptibility genes for Addison's disease. DESIGN AND METHODS: Addison's disease patients from three European populations were analysed for selected HLA-DR-DQ alleles and for 11 microsatellite markers covering approximately 4 Mb over the HLA region. Subjects were 69 patients with Addison's disease from Estonia (24), Finland (14) and Russia (31). Consecutively recruited healthy newborns from the same geographical regions were used as controls (269 Estonian, 1000 Finnish and 413 Russian). Association measures for HLA-DRB1, DQB1, DQA1 and 11 microsatellites between D6S273 and D6S2223 were taken. A low-resolution full-house typing was used for HLA class II genes, while microsatellite markers were studied using fluorescence-based DNA fragment sizing technology.
RESULTS: We confirmed that the HLA-DR3-DQ2 and the DQB1*0302-DRB1*0404 haplotypes confer disease susceptibility. In Russian patients, we also found an increase of DRB1*0403 allele, combined with DQB1*0305 allele in three out of six cases (P<0.0001). Analysis of 11 microsatellite markers including STR MICA confirmed the strong linkage in DR3-DQ2 haplotypes but DRB1*0404-DQB1*0302 haplotypes were diverse. MICA5.1 allele was found in 22 out of 24 Estonian patients, but results from Finnish and Russian patients did not support its independent role in disease susceptibility.
CONCLUSION: HLA-DRB1*0403 was identified as a novel susceptibility allele for Addison's disease. Additionally, we found no evidence of a non-class II HLA disease susceptibility locus; however, the HLA-DR3-DQ2 haplotype appeared more conserved in patient groups with high DR-DQ2 frequencies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18057383     DOI: 10.1530/EJE-07-0290

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  13 in total

1.  Genetic determinants of 21-hydroxylase autoantibodies amongst patients of the Type 1 Diabetes Genetics Consortium.

Authors:  Peter Baker; Pam Fain; Heinrich Kahles; Liping Yu; John Hutton; Janet Wenzlau; Marian Rewers; Klaus Badenhoop; George Eisenbarth
Journal:  J Clin Endocrinol Metab       Date:  2012-06-20       Impact factor: 5.958

2.  DLA class II haplotypes show sex-specific associations with primary hypoadrenocorticism in Standard Poodle dogs.

Authors:  Amy E Treeful; Aaron K Rendahl; Steven G Friedenberg
Journal:  Immunogenetics       Date:  2019-04-09       Impact factor: 2.846

3.  Predicting the onset of Addison's disease: ACTH, renin, cortisol and 21-hydroxylase autoantibodies.

Authors:  Peter R Baker; Priyaanka Nanduri; Peter A Gottlieb; Liping Yu; Georgeanna J Klingensmith; George S Eisenbarth; Jennifer M Barker
Journal:  Clin Endocrinol (Oxf)       Date:  2012-05       Impact factor: 3.478

4.  Dominant suppression of Addison's disease associated with HLA-B15.

Authors:  Peter R Baker; Erin E Baschal; Pam R Fain; Priyaanka Nanduri; Taylor M Triolo; Janet C Siebert; Taylor K Armstrong; Sunanda R Babu; Marian J Rewers; Peter A Gottlieb; Jennifer M Barker; George S Eisenbarth
Journal:  J Clin Endocrinol Metab       Date:  2011-05-11       Impact factor: 5.958

5.  Expanded dog leukocyte antigen (DLA) single nucleotide polymorphism (SNP) genotyping reveals spurious class II associations.

Authors:  N Safra; N C Pedersen; Z Wolf; E G Johnson; H W Liu; A M Hughes; A Young; D L Bannasch
Journal:  Vet J       Date:  2011-07-07       Impact factor: 2.688

6.  Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease.

Authors:  Peter R Baker; Erin E Baschal; Pam R Fain; Taylor M Triolo; Priyaanka Nanduri; Janet C Siebert; Taylor K Armstrong; Sunanda R Babu; Marian J Rewers; Peter A Gottlieb; Jennifer M Barker; George S Eisenbarth
Journal:  J Clin Endocrinol Metab       Date:  2010-07-14       Impact factor: 5.958

Review 7.  The genetics of autoimmune Addison disease: past, present and future.

Authors:  Ellen C Røyrvik; Eystein S Husebye
Journal:  Nat Rev Endocrinol       Date:  2022-04-11       Impact factor: 47.564

8.  Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes.

Authors:  Taylor M Triolo; Erin E Baschal; Taylor K Armstrong; Carrie S Toews; Pamela R Fain; Marian J Rewers; Liping Yu; Dongmei Miao; George S Eisenbarth; Peter A Gottlieb; Jennifer M Barker
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

9.  Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus.

Authors:  Anna L Mitchell; Anette Bøe Wolff; Katie MacArthur; Jolanta U Weaver; Bijay Vaidya; Martina M Erichsen; Rebecca Darlay; Eystein S Husebye; Heather J Cordell; Simon H S Pearce
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

Review 10.  Autoimmune Addison disease: pathophysiology and genetic complexity.

Authors:  Anna L Mitchell; Simon H S Pearce
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.